| Literature DB >> 31487681 |
Samir Gupta1, Dawn Provenzale2, Xavier Llor3, Amy L Halverson4, William Grady5, Daniel C Chung6, Sigurdis Haraldsdottir7, Arnold J Markowitz8, Thomas P Slavin9, Heather Hampel, Reid M Ness10, Jennifer M Weiss11, Dennis J Ahnen12, Lee-May Chen13, Gregory Cooper14, Dayna S Early15, Francis M Giardiello16, Michael J Hall17, Stanley R Hamilton18, Priyanka Kanth19, Jason B Klapman20, Audrey J Lazenby21, Patrick M Lynch18, Robert J Mayer22, June Mikkelson, Shajan Peter23, Scott E Regenbogen24, Mary A Dwyer, Ndiya Ogba25.
Abstract
Identifying individuals with hereditary syndromes allows for improved cancer surveillance, risk reduction, and optimized management. Establishing criteria for assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the assessment and management of patients with high-risk colorectal cancer syndromes. These NCCN Guidelines Insights focus on criteria for the evaluation of Lynch syndrome and considerations for use of multigene testing in the assessment of hereditary colorectal cancer syndromes.Entities:
Mesh：
Year: 2019 PMID： 31487681 DOI： 10.6004/jnccn.2019.0044
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908